118 related articles for article (PubMed ID: 16547169)
1. Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation.
Park SY; Lee JH; Kim CD; Lee WS; Park WS; Han J; Kwak YG; Kim KY; Hong KW
J Pharmacol Exp Ther; 2006 Jun; 317(3):1238-45. PubMed ID: 16547169
[TBL] [Abstract][Full Text] [Related]
2. Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation.
Park SY; Lee JH; Kim YK; Kim CD; Rhim BY; Lee WS; Hong KW
J Pharmacol Exp Ther; 2005 Mar; 312(3):1241-8. PubMed ID: 15525793
[TBL] [Abstract][Full Text] [Related]
3. 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts.
Fukasawa M; Nishida H; Sato T; Miyazaki M; Nakaya H
J Pharmacol Exp Ther; 2008 Jul; 326(1):100-4. PubMed ID: 18381926
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation.
Hong KW; Kim KY; Shin HK; Lee JH; Choi JM; Kwak YG; Kim CD; Lee WS; Rhim BY
J Pharmacol Exp Ther; 2003 Sep; 306(3):1182-90. PubMed ID: 12807996
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol.
Lee JH; Oh GT; Park SY; Choi JH; Park JG; Kim CD; Lee WS; Rhim BY; Shin YW; Hong KW
J Pharmacol Exp Ther; 2005 May; 313(2):502-9. PubMed ID: 15734902
[TBL] [Abstract][Full Text] [Related]
7. Apurinic/apyrimidinic endonuclease1/redox factor-1 inhibits monocyte adhesion in endothelial cells.
Kim CS; Son SJ; Kim EK; Kim SN; Yoo DG; Kim HS; Ryoo SW; Lee SD; Irani K; Jeon BH
Cardiovasc Res; 2006 Feb; 69(2):520-6. PubMed ID: 16325162
[TBL] [Abstract][Full Text] [Related]
8. Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells.
Kim KY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Shin YW; Hong KW
J Pharmacol Exp Ther; 2004 Jan; 308(1):97-104. PubMed ID: 14569058
[TBL] [Abstract][Full Text] [Related]
9. Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation.
Kim MJ; Lee JH; Park SY; Hong KW; Kim CD; Kim KY; Lee WS
Pharmacol Res; 2006 Oct; 54(4):261-7. PubMed ID: 16822680
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
Hattori Y; Suzuki K; Tomizawa A; Hirama N; Okayasu T; Hattori S; Satoh H; Akimoto K; Kasai K
Cardiovasc Res; 2009 Jan; 81(1):133-9. PubMed ID: 18703532
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the relaxant response to N,N'-dipropyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine in porcine coronary arteries.
Moritz A; Gust R; Pertz HH
J Pharmacol Exp Ther; 2007 May; 321(2):699-706. PubMed ID: 17322023
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
Nishio Y; Kashiwagi A; Takahara N; Hidaka H; Kikkawa R
Horm Metab Res; 1997 Oct; 29(10):491-5. PubMed ID: 9405974
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide activates glibenclamide-sensitive K+ channels in urinary bladder myocytes through a c-GMP-dependent mechanism.
Deka DK; Brading AF
Eur J Pharmacol; 2004 May; 492(1):13-9. PubMed ID: 15145700
[TBL] [Abstract][Full Text] [Related]
14. The d5 dopamine receptor mediates large-conductance, calcium- and voltage-activated potassium channel activation in human coronary artery smooth muscle cells.
Natarajan A; Han G; Chen SY; Yu P; White R; Jose P
J Pharmacol Exp Ther; 2010 Feb; 332(2):640-9. PubMed ID: 19864616
[TBL] [Abstract][Full Text] [Related]
15. Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-alpha in endothelial cells.
Chen XL; Zhang Q; Zhao R; Ding X; Tummala PE; Medford RM
J Pharmacol Exp Ther; 2003 May; 305(2):573-80. PubMed ID: 12606638
[TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and increased phosphorylation of casein kinase2/Akt/ cyclic AMP response element binding protein via maxi-K channel opening in neuronal cells.
Kim KY; Lee JH; Park JH; Yoo MA; Kwak YG; Kim SO; Yoo SE; Hong KW
Eur J Pharmacol; 2004 Aug; 497(3):267-77. PubMed ID: 15336944
[TBL] [Abstract][Full Text] [Related]
17. Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle.
Li F; De Godoy M; Rattan S
J Pharmacol Exp Ther; 2004 Mar; 308(3):1111-20. PubMed ID: 14711933
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathway.
Shu M; Zhou Y; Zhu W; Zhang H; Wu S; Chen J; Yan G
Mol Pharmacol; 2012 Mar; 81(3):292-8. PubMed ID: 22172575
[TBL] [Abstract][Full Text] [Related]
19. Ca
Fusi F; Trezza A; Spiga O; Sgaragli G; Bova S
Biochem Pharmacol; 2017 Sep; 140():53-63. PubMed ID: 28583845
[TBL] [Abstract][Full Text] [Related]
20. The constitutive function of native TRPC3 channels modulates vascular cell adhesion molecule-1 expression in coronary endothelial cells through nuclear factor kappaB signaling.
Smedlund K; Tano JY; Vazquez G
Circ Res; 2010 May; 106(9):1479-88. PubMed ID: 20360250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
